CAD4TB: Artificial Intelligence software for tuberculosis detection

Updated Jan 15, 2021

CAD4TB: Artificial Intelligence software for tuberculosis detection

https://www.delft.care/cad4tb/

Delft Imaging

CAD4TB (Computer Aided Detection for Tuberculosis) is an artificial intelligence software which analyses a digital chest X-ray image, and gives an indication if the subject on the image has active TB.

The CAD4TB software starts with a quick inspection of X-ray images. It normalizes the image to correct for input from various modalities, and then detects different abnormal structures that may be related to TB. The system has been trained in the detection of these abnormalities by applying deep learning to tends-of-thousands of normal and abnormal X-rays from over 15 countries. CAD4TB also rec...

SEE ALL

Stage 6: Sustained Scale

CAD4TB is CE-certified, validated through over 50 publications, implemented in 40 countries, and has screened over 6 million people for tuberculosis.

Focus Areas:

Infectious & Vector Diseases, Medical Devices, AI and 1 MoreSEE ALL

Implemented In:

Zambia, South Africa, Papua New Guinea and 26 MoreSEE ALL

6,000,000

Lives Impacted to Date

Key Partner

Countries Implemented In

Employees

‹›

Problem

Most countries where TB is widespread are resource-constrained; its prevalence tends to be higher in countries with lower per-capita GDP. It is, therefore, not surprising that one of the main reasons TB incidences have not significantly decreased is the lack of simple, effective and inexpensive ways to detect new TB cases at an early stage. While the only way to diagnose TB is with tests, they are usually high-cost.

}

Solution

Delft Imaging has solved the TB detection challenge by combining low-cost, quick digital X-rays with deep learning and remote expertise. It’s called CAD4TB (Computer-Aided Detection for Tuberculosis). CAD4TB takes PA Chest X-ray as input, and produces abnormality score (0-100) and heatmap as output. if TB is likely present in a patient, a follow-up test such as GeneXpert can be administered. This way, a patient can be diagnosed and treated within one day. Subject age is 4 years or above.

Mission and Vision

Delft Imaging is a social enterprise and envisions a world in which everyone can benefit from the modern world advances in the field of healthcare. It is this belief that drives our mission to develop and deliver unique health innovations, particularly affordable, innovative diagnostic imaging devices, and e-health software that respond to the specific needs of vulnerable communities around the world. Delft Imaging has particularly been focusing on the screening for TB with CAD4TB.

Competitive Advantage

Delft’s innovative approach to screening and diagnosing tuberculosis has been supported by many of our colleagues in the scientific community. The in-depth evaluations of CAD4TB in scientific articles are available (https://www.delft.care/publications/).

The Team Behind the Innovation

Our in-house expertise ranges from software development, engineering to public health and international business developers. Altogether, this diverse range of expertise is what has allowed us to screen over 6 million people in 40 countries through our tuberculosis-focused projects. We wish to apply our market knowledge and expertise into other areas of point of care diagnostics in developing countries.